Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.82 USD | -4.56% | +40.05% | +164.57% |
Apr. 29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
Apr. 29 | Cullinan Therapeutics, Inc Appoints Mary Kay Fenton as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+164.57% | 1.21B | |
+20.70% | 42.68B | |
-2.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.92% | 24.94B | |
-19.68% | 18.96B | |
+30.30% | 12.3B | |
-2.70% | 11.95B | |
-2.98% | 11.55B |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.
- Cullinan Oncology : HC Wainwright Adjusts Cullinan Management PT to $55 From $48, Maintains Buy Rating